Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cell therapy for autoimmune diseases: does it have a future?

A Radbruch1, A Thiel

  • 1German Rheumatism Research Centre Berlin, Schumannstr. 21/22, 10117 Berlin, Germany. radbruch@drfz.de

Annals of the Rheumatic Diseases
|October 14, 2004
PubMed
Summary

Future autoimmune disease therapies may involve eliminating specific immune cells rather than broadly suppressing immunity. This targeted cell therapy approach could offer curative potential and long-term remission for rheumatic diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for the Y(2175) in the Photoproduction Cross Section Measurement of γp→ϕπ^{+}π^{-}p at GlueX.

Physical review letters·2026
Same author

Upper Limit on the Photoproduction Cross Section of the Spin-Exotic π_{1}(1600).

Physical review letters·2025
Same author

High-Statistics Measurement of Collins and Sivers Asymmetries for Transversely Polarized Deuterons.

Physical review letters·2024
Same author

Final COMPASS Results on the Transverse-Spin-Dependent Azimuthal Asymmetries in the Pion-Induced Drell-Yan Process.

Physical review letters·2024
Same author

Adverse respiratory patterns in near-term spontaneously breathing newborn lambs with elevated airway liquid volumes at birth.

Frontiers in pediatrics·2024
Same author

First Measurement Using Elliptically Polarized Photons of the Double-Polarization Observable E for γp→pπ^{0} and γp→nπ^{+}.

Physical review letters·2024

Area of Science:

  • Immunology
  • Rheumatology
  • Cell Therapy

Background:

  • Current autoimmune disease treatments primarily rely on systemic immune suppression, which is not curative.
  • Biologicals like tumor necrosis factor (TNF) blocking antibodies offer targeted inflammation suppression in rheumatic diseases.
  • Limitations exist in current therapies, necessitating more specific and curative approaches.

Purpose of the Study:

  • To review the current state of therapeutic concepts for autoimmune diseases.
  • To explore future therapeutic strategies focused on specific modulation of pathogenic cells.
  • To highlight the potential of cell therapy as a curative alternative for rheumatic diseases.

Main Methods:

  • Review of existing literature on autoimmune disease therapies.

Related Experiment Videos

  • Analysis of current and emerging cell-targeting strategies.
  • Discussion of the potential for eliminating specific immune cells and regulatory cells.

    • Main Results:

    • Eliminating inflammatory mediator-secreting cells offers greater therapeutic advantage than blocking secreted molecules.
    • Targeting both effector cells and regulatory cells may induce long-term remission.
    • Basic tools for specific cell therapy are becoming available.

    Conclusions:

    • Future therapies for autoimmune diseases should focus on specific cell elimination or modulation.
    • Cell therapy represents a promising, potentially curative alternative to conventional treatments for rheumatic diseases.
    • Direct and specific cell therapy could revolutionize the management of autoimmune and rheumatic conditions.